Prognostic prediction of systemic immune-inflammation status for patients with colorectal cancer: a novel pyroptosis-related model
Rattachement africain : cn. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Pyroptosis and related gasdermin family proteins play an important role in the tumorigenesis of colorectal cancer (CRC). However, the prognostic roles of pyroptosis-related genes (PRGs) and their relation to infiltrates of immune cells in the pathogenesis of CRC remain unclear. Using this study, we set up a prognostic gene pattern on the basis of 13 PRGs (AIM2, CASP1, CASP5, CASP6, CASP8, CASP9, ELANE, GPX4, GSDMD, NLRP7, NOD2, PJVK, and PRKACA) for CRC patients. A comprehensive bioinformatics analysis based on these genes was then performed. With the good AUC prediction value of the ROC curves, the group with high hazard first had a poorer survival prognosis than the group with low hazard. Second, we found that PRGs were significantly related to inflammation-associated genes and immune-associated genes in CRC. Then, we identified a correlation of PRGs with immune infiltrations in CRC. For instance, the abundances of resting NK cells resting and neutrophils were higher in the low hazard group than in the high hazard group. Overall, this work indicated that PRGs contributed to generate heterogeneity of the tumor microenvironment (TME) in CRC. This prognostic PRG model may provide a starting point for the early diagnosis and medication use of CRC.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Prognostic prediction of systemic immune-inflammation status for patients with colorectal cancer: a novel pyroptosis-related model
- Date Crossref
- 14/07/2022
- Éditeur
- Springer Science and Business Media LLC
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Tianjin Medical University Cancer Institute and Hospital Department of Colorectal Cancer Surgery pays non établi dans la noticeÉtablissement de santé
-
Tianjin People's Hospital pays non établi dans la noticeÉtablissement de santé
-
Tianjin Marvel Medical Laboratory pays non établi dans la noticeStructure de recherche
-
Ltd. Tianjin Yunquan Intelligent Technology Co. pays non établi dans la noticeEntreprise
-
The People's Hospital of Tianjin Department of Colorectal Surgery pays non établi dans la noticeÉtablissement de santé
Department of Colorectal Cancer Surgery — Tianjin Medical University Cancer Institute and Hospital, Tianjin People's Hospital et Tianjin Marvel Medical Laboratory, avec 2 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.